{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:01:08Z","timestamp":1760425268080,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["20907019"],"award-info":[{"award-number":["20907019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"publisher","award":["20090211120001","20110211110032"],"award-info":[{"award-number":["20090211120001","20110211110032"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejphar.2014.09.037","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T22:22:48Z","timestamp":1412115768000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Alpha-lipoic acid attenuates cardiac hypertrophy via downregulation of PARP-2 and subsequent activation of SIRT-1"],"prefix":"10.1016","volume":"744","author":[{"given":"Lan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erqing","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.09.037_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1043661802002311","article-title":"Alpha-lipoic acid ameliorates myocardial toxicity induced by doxorubicin","volume":"46","author":"Al-Majed","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2014.09.037_bib2","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","article-title":"Sirt1 regulates aging and resistance to oxidative stress in the heart","volume":"100","author":"Alcendor","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.09.037_bib3","doi-asserted-by":"crossref","first-page":"17860","DOI":"10.1074\/jbc.274.25.17860","article-title":"PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase","volume":"274","author":"Ame","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.09.037_bib4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cmet.2011.03.013","article-title":"PARP-2 regulates SIRT1 expression and whole-body energy expenditure","volume":"13","author":"Bai","year":"2011","journal-title":"Cell. Metab."},{"key":"10.1016\/j.ejphar.2014.09.037_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1382-6689(01)00080-1","article-title":"The therapeutic use of lipoic acid in diabetes: a current perspective","volume":"10","author":"Coleman","year":"2001","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.037_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yrtph.2006.06.004","article-title":"Safety evaluation of alpha-lipoic acid (ALA)","volume":"46","author":"Cremer","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.037_bib7","doi-asserted-by":"crossref","first-page":"e58371","DOI":"10.1371\/journal.pone.0058371","article-title":"alpha-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia\/reperfusion injury through activation of PI3K\/Akt\/Nrf2 pathway","volume":"8","author":"Deng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2014.09.037_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1440-1681.2002.03642.x","article-title":"Effect of alpha-lipoic acid on lipid peroxidation and anti-oxidant enzyme activities in diabetic rats","volume":"29","author":"Dincer","year":"2002","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2014.09.037_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/hy0202.104345","article-title":"Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid","volume":"39","author":"El Midaoui","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2014.09.037_bib10","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: a new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2014.09.037_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2014.09.037_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10616-006-6334-6","article-title":"An optimized protocol for culture of cardiomyocyte from neonatal rat","volume":"49","author":"Fu","year":"2005","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ejphar.2014.09.037_bib13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bbrc.2012.11.132","article-title":"PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1","volume":"430","author":"Geng","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2014.09.037_bib14","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.biocel.2008.03.008","article-title":"Identification of lysines 36 and 37 of PARP-2 as targets for acetylation and auto-ADP-ribosylation","volume":"40","author":"Haenni","year":"2008","journal-title":"Int. J. Biochem. Cell B"},{"key":"10.1016\/j.ejphar.2014.09.037_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2840-11-73","article-title":"Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2014.09.037_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1139\/Y08-099","article-title":"Sirt1 hyperexpression in SHR heart related to left ventricular hypertrophy","volume":"87","author":"Li","year":"2009","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.037_bib17","doi-asserted-by":"crossref","first-page":"590363","DOI":"10.1155\/2013\/590363","article-title":"The protective effect of alpha-lipoic acid in lipopolysaccharide-induced acute lung injury is mediated by heme oxygenase-1","volume":"2013","author":"Lin","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.ejphar.2014.09.037_bib18","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.addr.2008.04.015","article-title":"Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer\u05f3s disease","volume":"60","author":"Maczurek","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2014.09.037_bib19","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJM199012133232413","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"323","author":"Manyari","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2014.09.037_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2014.09.037_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S0007114510003107","article-title":"alpha-Lipoic acid has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations","volume":"105","author":"Odabasoglu","year":"2011","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejphar.2014.09.037_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/03602539808996311","article-title":"alpha-Lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury","volume":"30","author":"Packer","year":"1998","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejphar.2014.09.037_bib23","first-page":"293","article-title":"Absorption of [7,8-14C]rac-a-lipoic acid from in situ ligated segments of the gastrointestinal tract of the rat","volume":"45","author":"Peter","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejphar.2014.09.037_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/bbrc.1994.2431","article-title":"Alpha-lipoic acid supplementation prevents symptoms of vitamin E deficiency","volume":"204","author":"Podda","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2014.09.037_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2014.09.037_bib26","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2014.09.037_bib27","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1007\/s00018-012-1003-8","article-title":"Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein","volume":"69","author":"Szanto","year":"2012","journal-title":"Cell. Mol. Life. Sci."},{"key":"10.1016\/j.ejphar.2014.09.037_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1027354005498","article-title":"Salt-induced hypertension in WKY rats: prevention by alpha-lipoic acid supplementation","volume":"254","author":"Vasdev","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2014.09.037_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11010-005-1095-7","article-title":"Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats","volume":"275","author":"Vasdev","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2014.09.037_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2840-12-50","article-title":"Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy","volume":"12","author":"Wen","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2014.09.037_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1476-511X-11-148","article-title":"Flaxseed oil and alpha-lipoic acid combination reduces atherosclerosis risk factors in rats fed a high-fat diet","volume":"11","author":"Xu","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejphar.2014.09.037_bib32","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc06-1216","article-title":"Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy\u2014the SYDNEY 2 trial","volume":"29","author":"Ziegler","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2014.09.037_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mce.2013.03.006","article-title":"Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-alpha partly via preventing p65-NFkappaB binding to NFATc4","volume":"370","author":"Zou","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2014.09.037_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.104.1.97","article-title":"Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy","volume":"104","author":"Zou","year":"2001","journal-title":"Circulation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914006931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914006931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:20:24Z","timestamp":1757974824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914006931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":34,"alternative-id":["S0014299914006931"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.037","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-lipoic acid attenuates cardiac hypertrophy via downregulation of PARP-2 and subsequent activation of SIRT-1","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}